Regeneron Pharmaceuticals, Inc.
Long
Updated

$REGN:NASDAQ - REGENERON PHARMACEUTICALS

126
Regeneron has been having a nice run since the end of last year and is up around 100%. Financials look pretty strong. Could be worth a watch.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP.
Note
Hasn't done much. Small gain, but the volume over the last few days has been interesting. Have set an alert to have another look if it moves above $590.

snapshot
Note
Nice explosive move out of its channel.

snapshot

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.